February 19, 2026 · Form 4 insider transaction
Fried Robert N bought 503,937 shares of Niagen Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
One-fourth of the shares subject to the option shall vest on each anniversary of the grant date.